Back
Voyager Therapeutics Vs. Neurocrine Biosciences Industry Stock Comparison
Sell
48
VYGR
Voyager Therapeutics
Last Price:
7.81
Seasonality Move:
1.94%
Buy
70
NBIX
Neurocrine Biosciences
Last Price:
137.49
Seasonality Move:
8.72%
Sell
48
Voyager Therapeutics (VYGR)
is a Sell
Is Voyager Therapeutics a Buy, Sell or Hold?
- The current Voyager Therapeutics [VYGR] share price is $7.80. The Score for VYGR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- VYGR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy, Sell or Hold?
- The current Neurocrine Biosciences [NBIX] share price is $137.48. The Score for NBIX is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- NBIX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VYGR Stock Price Chart
What is Voyager Therapeutics's stock price today?
-
The Voyager Therapeutics share price today is $7.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VYGR is experiencing slight buying pressure.
NBIX Stock Price Chart
What is Neurocrine Biosciences's stock price today?
-
The Neurocrine Biosciences share price today is $137.48
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing selling pressure, which indicates risk of future bearish movement.
VYGR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.39 | Sell |
Relative Strength Index (14 RSI): | 41.7 | Sell |
Chaikin Money Flow: | 195482 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.63 - 9.47) | Sell |
Bollinger Bands (100): | (7.47 - 9.27) | Sell |
NBIX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 51.56 | Buy |
Chaikin Money Flow: | -731897 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (134.14 - 139.68) | Buy |
Bollinger Bands (100): | (128.08 - 140.68) | Buy |
VYGR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.61 | Buy |
20-day SMA: | 8.22 | Sell |
50-day SMA: | 8.77 | Sell |
200-day SMA: | 8.2 | Sell |
8-day EMA: | 7.74 | Buy |
20-day EMA: | 8.12 | Sell |
50-day EMA: | 8.42 | Sell |
200-day EMA: | 8.31 | Sell |
NBIX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 136.87 | Buy |
20-day SMA: | 136.34 | Buy |
50-day SMA: | 136.76 | Buy |
200-day SMA: | 121.82 | Buy |
8-day EMA: | 137.04 | Buy |
20-day EMA: | 136.76 | Buy |
50-day EMA: | 136.19 | Buy |
200-day EMA: | 124.82 | Buy |
Voyager Therapeutics Earnings Growth & VYGR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.11 per share, a decrease this year of $3.25 per share, and an increase next year of $0.04 per share.
Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.10 per share, an increase this year of $1.88 per share, and an increase next year of $1.78 per share.
Voyager Therapeutics Technical Analysis
Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurocrine Biosciences Technical Analysis
Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |